[37], which demonstrated that decitabine, an inhibitor of DNA methyltransferase 1 (DNMT1) suppresses the proliferation of IDH‐mutant glioma cells both in vitro and in vivo. This evidence concerns the gene IDH2 and central nervous system cancer.